Ting Lu

Dr. Ting Lu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2012 in IEEE Communications Letters
Verified
Journal Article
Closed access
TLTing Lu
Ting Lu
JZJie Zhu
Jie Zhu
The consideration of energy consumption in wireless ad hoc networks prevents the problem of the network exhausting batteries, thus partitioning the entire network. Power-aware multicasting is proposed to reduce the power consumption. This letter presents an energy-efficient genetic algorithm mechanism to resolve quality of service (QoS) multicast routing problem, which is NP-complete. The proposed genetic algorithm depends on bounded end-to-end delay and minimum energy cost of the multicast tree. Simulation results show that the proposed algorithm is effective and efficient.

6 May 2017 in Peer-to-Peer Networking and Applications
Verified
Journal Article
Closed access
PDF file
TLTing Lu
Ting Lu
SCShan Chang
Shan Chang
WLWei Li
Wei Li

1 February 2013 in Applied Soft Computing
Verified
Journal Article
Closed access
TLTing Lu
Ting Lu
JZJie Zhu
Jie Zhu

31 August 2016 in Wireless Networks
Verified
Journal Article
Closed access
PDF file
TLTing Lu
Ting Lu
GLGuohua Liu
Guohua Liu
SCShan Chang
Shan Chang

24 October 2022 in Theranostics
Verified
Journal Article
Open access
PDF file
TCTao Chen
Tao Chen
ZYZhiqing Yuan
Zhiqing Yuan
ZLZhou Lei
Zhou Lei
JDJinlin Duan
Jinlin Duan
JXJunyan Xue
Junyan Xue
YZYonglong Zhang
Yonglong Zhang
Rationale: Hepatocellular carcinoma (HCC) is one of the most severe cancers worldwide, with few effective targeted therapies for HCC. Lipid metabolic reprogramming is emerged as a hallmark of cancer metabolism that guides response to antitumoral therapies. Such lipid metabolic alteration in cancers is critically regulated by the mammalian target of rapamycin mTOR, which is considered as a promising therapeutic target. Despite efforts, mTOR inhibitors (mTORi) have produced limited response clinically, partly due to incomplete knowledge of mTORC1 addiction in cancers.

31 March 2020 in Peer-to-Peer Networking and Applications
Verified
Journal Article
Closed access
PDF file
ZRZibin Ren
Zibin Ren
TLTing Lu
Ting Lu
XWXin Wang
Xin Wang
WGWenJing Guo
WenJing Guo
GLGuohua Liu
Guohua Liu
SCShan Chang
Shan Chang